AGIO
Agios Pharmaceuticals, Inc.
31.80$
-2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -7.0% | -9.3% | -9.0% | +131.8% | -7.2% | -6.5% | -5.4% | -5.8% | -6.4% | -8.7% | -6.5% | |
| – | +18.4% | -20.4% | -4.7% | +69.9% | -10.1% | +0.3% | +5.2% | +1.3% | -8.8% | -11.4% | -14.0% | |
| – | +37.1% | +34.6% | -28.8% | +200.2% | -69.9% | +3.6% | +2.4% | +14.6% | -3.9% | +27.5% | -12.3% | |
| – | +20.0% | -23.0% | -4.7% | +76.3% | -11.1% | 0.0% | +5.1% | +1.5% | -10.3% | -13.7% | -16.2% | |
| – | +138.9% | +22.9% | +8.9% | -17.1% | +31.8% | -18.6% | +49.1% | +0.9% | +110.3% | +52.5% | +24.7% | |
| – | +10.4% | +20.9% | +3.8% | +10.4% | +4.5% | +7.2% | +4.2% | +3.8% | +2.8% | +6.6% | -14.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.7% | -16.1% | +6.4% | +46.7% | -26.0% | -27.2% | +14.3% | -0.3% | +2.7% | -27.1% | +8.6% | |
| – | +16.3% | -23.9% | +21.2% | +90.7% | -32.1% | -35.5% | +34.5% | +6.2% | +10.0% | -28.4% | +19.3% | |
| – | +2.3% | +2.7% | +2.9% | +2.9% | +2.8% | +2.5% | +2.3% | +2.3% | +2.3% | +2.2% | +2.2% | |
| – | -26.3% | +14.1% | -10.0% | +70.8% | -2.9% | -17.5% | +27.7% | +11.5% | -6.1% | -25.1% | +18.9% | |
| – | -8.5% | -8.3% | -11.2% | +146.3% | -5.3% | -4.8% | -6.6% | -6.2% | -7.1% | -7.0% | -7.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +0.9% | +0.7% | +2.9% | -2.2% | +0.5% | +0.8% | +0.4% | +0.3% | +0.8% | +1.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.